Hashmi, H.B.; Farooq, M.A.; Khan, M.H.; Alshammari, A.; Aljasham, A.T.; Rashid, S.A.; Khan, N.R.; Hashmi, I.B.; Badar, M.; Mubarak, M.S.
Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms. Pharmaceuticals 2023, 16, 687.
https://doi.org/10.3390/ph16050687
AMA Style
Hashmi HB, Farooq MA, Khan MH, Alshammari A, Aljasham AT, Rashid SA, Khan NR, Hashmi IB, Badar M, Mubarak MS.
Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms. Pharmaceuticals. 2023; 16(5):687.
https://doi.org/10.3390/ph16050687
Chicago/Turabian Style
Hashmi, Hamna Batool, Muhammad Asad Farooq, Muhammad Hashim Khan, Abdulrahman Alshammari, Alanoud T. Aljasham, Sheikh Abdur Rashid, Nauman Rahim Khan, Irum Batool Hashmi, Muhammad Badar, and Mohammad S. Mubarak.
2023. "Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms" Pharmaceuticals 16, no. 5: 687.
https://doi.org/10.3390/ph16050687
APA Style
Hashmi, H. B., Farooq, M. A., Khan, M. H., Alshammari, A., Aljasham, A. T., Rashid, S. A., Khan, N. R., Hashmi, I. B., Badar, M., & Mubarak, M. S.
(2023). Collaterally Sensitive β-Lactam Drugs as an Effective Therapy against the Pre-Existing Methicillin Resistant Staphylococcus aureus (MRSA) Biofilms. Pharmaceuticals, 16(5), 687.
https://doi.org/10.3390/ph16050687
